实用肿瘤学杂志 ›› 2026, Vol. 40 ›› Issue (1): 9-15.doi: 10.11904/j.issn.1002-3070.2026.01.002

• 癌情监测 • 上一篇    下一篇

2011—2021年常州市前列腺癌发病与死亡的年龄变化趋势及预测分析

华天齐1, 褚叶琳2, 徐文超1, 骆文书1   

  1. 1.常州市疾病预防控制中心慢性非传染性疾病防制科/办公室(常州 213022);
    2.南京医科大学第三附属医院(常州市第二人民医院)疼痛科
  • 收稿日期:2025-05-06 修回日期:2026-01-30 出版日期:2026-02-28 发布日期:2026-02-27
  • 通讯作者: 骆文书,E-mail:luowenshu33@163.com
  • 作者简介:华天齐,男,(1992—),硕士,主管医师,主要从事慢性病防制相关的研究。
  • 基金资助:
    常州市软科学研究项目(编号:CR20241123);常州市卫健委科技项目(编号:ZD202350)

Trends and predictive analysis of age-specific incidence and mortality of prostate cancer in Changzhou City from 2011 to 2021

HUA Tianqi1, CHU Yelin2, XU Wenchao1, LUO Wenshu1   

  1. 1. Department/Office of Chronic Non-communicable Disease Prevention and Control,Changzhou Center for Disease Control and Prevention,Changzhou 213022,China;
    2. Pain Management Department,The Third Affiliated Hospital of Nanjing Medical University(Changzhou Second People′s Hospital)
  • Received:2025-05-06 Revised:2026-01-30 Online:2026-02-28 Published:2026-02-27

摘要: 目的 分析2011—2021年常州市前列腺癌发病与死亡率变化趋势,并预测未来5年前列腺癌的发病率和死亡率,为公共卫生政策制定提供科学依据。方法 采用常州市肿瘤登记处2011—2021年前列腺癌监测数据,计算各年份前列腺癌的发病率、死亡率及标化率等指标。使用Joinpoint 5.1.0分析前列腺癌发病与死亡变化趋势,计算平均年度变化百分比(average annual percentage change,AAPC)。采用线性回归模型分析平均发病年龄和平均死亡年龄与年份的相关性。构建出生队列模型,分析不同出生年份人群前列腺癌发病率和死亡率的年龄变化特征。进一步构建自回归积分滑动平均(autoregressive integrated moving average,ARIMA)模型,对2022—2026年前列腺癌发病率和死亡率进行预测。结果 2011—2021年常州市前列腺癌中标发病率为15.75/10万,中标死亡率为5.03/10万。中标发病率由2011年的8.71/10万上升至2021年的21.68/10万,AAPC为9.48%(95% CI:7.43%~11.57%);中标死亡率由2.87/10万升至6.41/10万,AAPC为7.96%(95% CI:4.90%~11.12%)。年龄别分析显示,60~69岁人群发病率增长最快,AAPC为12.86%(95% CI:11.45%~14.68%);80岁以上人群死亡率增长最快,AAPC为10.42%(95% CI:7.67%~15.48%)。2011—2021年实际平均发病年龄呈逐年降低趋势(P=0.013),而实际平均死亡年龄和标化平均死亡年龄呈逐年升高趋势(P<0.05)。ARIMA预测显示,未来5年常州市前列腺癌中标发病率和中标死亡率将持续上升,中标发病率由22.88/10万增至28.04/10万,中标死亡率由6.34/10万增至6.35/10万。结论 常州市前列腺癌的发病率和死亡率呈上升趋势,且预计未来5年仍将继续增加。应进一步加强前列腺癌的早期筛查与规范诊治,重点关注50岁及以上男性人群,以有效降低疾病负担。

关键词: 前列腺癌, 发病, 死亡, 趋势分析

Abstract: Objective This study aimed to analyze the trends in the incidence and mortality of prostate cancer in Changzhou City from 2011 to 2021,and to predict the incidence and mortality of prostate cancer over the next five years,providing a scientific basis for the formulation of public health policy. Methods The surveillance data of prostate cancer from 2011 to 2021 in the Changzhou Cancer Registry were used to calculate the incidence,mortality,and standardized rates of prostate cancer for each year.The Joinpoint Regression Program(version 5.1.0)was employed to analyze the trends in the incidence and mortality of prostate cancer,and the average annual percentage change(AAPC)was calculated.Linear regression models were used to analyze the correlation between the average age of incidence and the average age of death with the year.A birth cohort model was constructed to analyze the age-specific characteristics of the incidence and mortality of prostate cancer in different birth cohorts.Furthermore,an autoregressive integrated moving average(ARIMA)model was constructed to predict the prostate cancer incidence and mortality in Changzhou City from 2022 to 2026. Results From 2011 to 2021,age-standardized incidence rate by Chinese standard population(ASIRC)of prostate cancer in Changzhou City was 15.75 per 100,000,and age-standardized mortality rate by Chinese standard population(ASMRC)was 5.03 per 100,000.The ASIRC increased from 8.71 per 100,000 in 2011 to 21.68 per 100,000 in 2021,with an AAPC of 9.48%(95% CI:7.43%-11.57%).The ASMRC increased from 2.87 per 100,000 to 6.41 per 100,000,with an AAPC of 7.96%(95% CI:4.90%-11.12%).Age-specific analysis revealed that the incidence increased most rapidly in the 60-69 year age group,with an AAPC of 12.86%(95% CI:11.45%-14.68%);the mortality increased most rapidly in the population aged 80 and over,with an AAPC of 10.42%(95% CI:7.67%-15.48%).The actual average age of incidence showed a decreasing trend year by year from 2011 to 2021(P=0.013),whereas the actual and standardized average age of death showed an increasing trend year by year(P<0.05).The ARIMA predictions indicated that the ASIRC and ASMRC of prostate cancer in Changzhou City would continue to rise in the next 5 years,with ASIRC increasing from 22.88 per 100,000 to 28.04 per 100,000,and ASMRC increasing from 6.34 per 100,000 to 6.35 per 100,000. Conclusions The incidence and mortality of prostate cancer in Changzhou City are on the rise,and projected to continue increasing in the next five years.It is necessary to further strengthen early screening and standardized diagnosis and treatment of prostate cancer,with a focus on men aged 50 years and above,in order to effectively reduce the disease burden.

Key words: prostate cancer, incidence, mortality, trend analysis

中图分类号: